NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
3.255
-0.045 (-1.39%)
Nov 21, 2024, 10:58 AM EST - Market open
NEXGEL Revenue
NEXGEL had revenue of $2.94M in the quarter ending September 30, 2024, with 140.79% growth. This brings the company's revenue in the last twelve months to $6.73M, up 90.57% year-over-year. In the year 2023, NEXGEL had annual revenue of $4.09M with 99.66% growth.
Revenue (ttm)
$6.73M
Revenue Growth
+90.57%
P/S Ratio
3.24
Revenue / Employee
$354,158
Employees
19
Market Cap
24.47M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Neuronetics | 72.71M |
Bionano Genomics | 33.33M |
Bolt Biotherapeutics | 9.78M |
NeuroOne Medical Technologies | 3.92M |
NeurAxis | 2.46M |
NXGL News
- 7 days ago - NEXGEL, Inc. (NXGL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially - GlobeNewsWire
- 9 days ago - NEXGEL Announces $2,000,000 Registered Direct Offering - GlobeNewsWire
- 5 weeks ago - NEXGEL to Participate in Upcoming October Investor Conferences - GlobeNewsWire
- 6 weeks ago - NEXGEL Appoints Kip Crecca to its Scientific Advisory Board - GlobeNewsWire
- 3 months ago - NEXGEL, Inc. (NXGL) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million - GlobeNewsWire
- 3 months ago - NEXGEL to Report Second Quarter 2024 Financial Results on August 14th - GlobeNewsWire